Hu et al. found that elevated FAM83A expression in NSCLC is associated with poor prognosis, and FAM83A promotes tumorigenicity at least partly via the ERK and PI3K/Akt/mTOR pathways [37]. Here, MTOR is linked to non-small cell lung carcinoma.